Stress Echo 2030 The Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging /

Stress Echo 2030 The Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging /

With stress echo (SE) 2020 study, a new standard of practice in stress imaging was developed and disseminated: the ABCDE protocol for functional testing within and beyond CAD. ABCDE protocol was the fruit of SE 2020, and is the seed of SE 2030, which is articulated in 12 projects: 1-SE in coronary a...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Picano Eugenio
Ciampi Quirino
Cortigiani Lauro
Arruda-Olson Adelaide M.
Borguezan-Daros Clarissa
Castro e Silva Pretto, de José Luis
Cocchia Rosangela
Bossone Eduardo
Merli Elisa
Kane Garvan C.
Varga Albert
Ágoston Gergely
Pálinkás Attila
Pálinkás Eszter D.
Sepp Róbert
The Stress Echo 2030 Study Group of the Italian Society of Echoc and Cardiovascular Imaging
Dokumentumtípus: Cikk
Megjelent: 2021
Sorozat:JOURNAL OF CLINICAL MEDICINE 10 No. 16
Tárgyszavak:
Klinikai orvostan
doi:10.3390/jcm10163641

mtmt:32356318
Online Access:http://publicatio.bibl.u-szeged.hu/23302
Leíró adatok
Tartalmi kivonat:With stress echo (SE) 2020 study, a new standard of practice in stress imaging was developed and disseminated: the ABCDE protocol for functional testing within and beyond CAD. ABCDE protocol was the fruit of SE 2020, and is the seed of SE 2030, which is articulated in 12 projects: 1-SE in coronary artery disease (SECAD); 2-SE in diastolic heart failure (SEDIA); 3-SE in hypertrophic cardiomyopathy (SEHCA); 4-SE post-chest radiotherapy and chemotherapy (SERA); 5-Artificial intelligence SE evaluation (AI-SEE); 6-Environmental stress echocardiography and air pollution (ESTER); 7-SE in repaired Tetralogy of Fallot (SETOF); 8-SE in post-COVID-19 (SECOV); 9: Recovery by stress echo of conventionally unfit donor good hearts (RESURGE); 10-SE for mitral ischemic regurgitation (SEMIR); 11-SE in valvular heart disease (SEVA); 12-SE for coronary vasospasm (SESPASM). The study aims to recruit in the next 5 years (2021-2025) >= 10,000 patients followed for >= 5 years (up to 2030) from >= 20 quality-controlled laboratories from >= 10 countries. In this COVID-19 era of sustainable health care delivery, SE2030 will provide the evidence to finally recommend SE as the optimal and versatile imaging modality for functional testing anywhere, any time, and in any patient.
Terjedelem/Fizikai jellemzők:Terjedelem: 35 p-Azonosító: 3641
ISSN:2077-0383

Hasonló tételek